The influence of integrated tuberculosis and human immunodeficiency virus service delivery on patient outcomes

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 3, 2014, Pages 315-321

  Uyei, J ^a,b   Coetzee, D ^c   Macinko, J ^b   Weinberg, S L ^b   Guttmacher, S ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cape Town; Health services; South Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; HEALTH CARE SURVEY; HIV INFECTIONS; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MALE; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; STATISTICAL MODEL; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; COINFECTION; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PUBLIC HEALTH; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84894280556     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0184     Document Type: Article

References (20)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
2. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2010.
3. Gandhi N R, Moll A P, Lalloo U, et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study. J Acquir Immune Defic Syndr 2009; 50: 37-43.
4. Jack C, Lalloo U, Karim Q A, et al. A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36: 929-934.
5. Abdool Karim S S, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010; 362: 697-706.
6. Blanc F-X, Sok T, Laureillard D, et al. Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial. Paper presented at Institut Pasteur International Network Annual Scientific Meeting, Hong Kong, November 22-23, 2010. BMC Proceedings, 2010; 5 (Suppl 1): O11.
7. Lawn S D, Badri M, Wood R. Tuberculosis among HIVi nfected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005; 19: 2109-2116.
8. Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007; 21: 713-719.
9. Middelkoop K, Bekker L G, Myer L, et al. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011; 56: 263-269.
10. Anderson S R, Maher D. An analysis of interaction between TB and HIV/AIDS programmes in sub-Saharan Africa. Geneva, Switzerland: World Health Organization, Stop TB Department, 2001.
11. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis 2007; 196 (Suppl): S114-S123.
12. Tsiouris S J, Gandhi N R, El-Sadr W M, Gerald F. Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. J Int AIDS Soc 2007; 9: 62.
13. Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis 2011; 11: 855-867.
14. Wood R, Lawn S D, Caldwell J, Kaplan R, Middelkoop K, Bekker L G. Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLOS ONE 2011; 6: e25098.
15. National Department of Health. The 2011 National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa. Pretoria, South Africa: Department of Health, 2012.
16. Uyei J, Coetzee D, Macinko J, Weinberg S L, Guttmacher S. Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa. Health Policy Plan 2014; 29: 42-55.
17. Su Y, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R: opening windows into the black box. Journal of Statistical Software 2011; 45(2).
18. Romanovsky P, Gie J. The spacial distribution of socio-economic status, services levels and levels of living in the City of Cape Town, 2001-to highlight suburbs in need. Cape Town, South Africa: Information & Knowledge Management Department, Strategic Information Branch, Government of South Africa, March 2006. http://www.capetown.gov.za/en/stats/CityReports/ Documents/Households/Levels-of-Living-Report-26102006 13451-359.pdf Accessed January 2014.
19. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-129.
20. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9: A11-A15.